These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

444 related items for PubMed ID: 21865693

  • 1. IgA nephropathy and aberrant glycosylation of tonsillar, serum and glomerular IgA1.
    Hiki Y, Ito A, Yamamoto Y, Yamamoto K, Iwase H.
    Adv Otorhinolaryngol; 2011; 72():68-70. PubMed ID: 21865693
    [Abstract] [Full Text] [Related]

  • 2. IgA1 molecules produced by tonsillar lymphocytes are under-O-glycosylated in IgA nephropathy.
    Horie A, Hiki Y, Odani H, Yasuda Y, Takahashi M, Kato M, Iwase H, Kobayashi Y, Nakashima I, Maeda K.
    Am J Kidney Dis; 2003 Sep; 42(3):486-96. PubMed ID: 12955676
    [Abstract] [Full Text] [Related]

  • 3. IgA nephropathy and tonsils--an approach from the structure of IgA1 produced by tonsillar lymphocytes.
    Hiki Y, Horie A, Yasuda Y, Iwase H, Sugiyama S.
    Acta Otolaryngol Suppl; 2004 Dec; (555):28-31. PubMed ID: 15768794
    [Abstract] [Full Text] [Related]

  • 4. Similarities between N-glycan glycoform of tonsillar IgA1 and that of aberrant IgA1 abundant in IgA nephropathy patient serum.
    Iwanami N, Iwase H, Takahashi N, Kato K, Itoh A, Takatani T, Makita S, Kobayashi Y, Okamoto M, Nakamura S, Hiki Y, Ishii M.
    J Nephrol; 2008 Dec; 21(1):118-26. PubMed ID: 18264945
    [Abstract] [Full Text] [Related]

  • 5. Mass spectrometry proves under-O-glycosylation of glomerular IgA1 in IgA nephropathy.
    Hiki Y, Odani H, Takahashi M, Yasuda Y, Nishimoto A, Iwase H, Shinzato T, Kobayashi Y, Maeda K.
    Kidney Int; 2001 Mar; 59(3):1077-85. PubMed ID: 11231363
    [Abstract] [Full Text] [Related]

  • 6. Disordered balance of IgA subclass production in the tonsils of some IgA nephropathy patients.
    Itoh A, Iwase H, Takatani T, Nakamura I, Hayashi M, Kobayashi Y, Hiki Y, Okamoto M.
    J Nephrol; 2005 Mar; 18(5):575-81. PubMed ID: 16299684
    [Abstract] [Full Text] [Related]

  • 7. Pathogenesis of IgA nephropathy.
    Feehally J, Allen AC.
    Ann Med Interne (Paris); 1999 Feb; 150(2):91-8. PubMed ID: 10392257
    [Abstract] [Full Text] [Related]

  • 8. The glycans deficiencies of macromolecular IgA1 is a contributory factor of variable pathological phenotypes of IgA nephropathy.
    Xu LX, Yan Y, Zhang JJ, Zhang Y, Zhao MH.
    Clin Exp Immunol; 2005 Dec; 142(3):569-75. PubMed ID: 16297170
    [Abstract] [Full Text] [Related]

  • 9. Activation of the interleukin-4/signal transducer and activator of transcription 6 signaling pathway and homeodomain-interacting protein kinase 2 production by tonsillar mononuclear cells in IgA nephropathy.
    He L, Peng Y, Liu H, Yin W, Chen X, Peng X, Shao J, Liu Y, Liu F.
    Am J Nephrol; 2013 Dec; 38(4):321-32. PubMed ID: 24107646
    [Abstract] [Full Text] [Related]

  • 10. Aberrant glycosylation of IgA1 and anti-glycan antibodies in IgA nephropathy: role of mucosal immune system.
    Novak J, Moldoveanu Z, Julian BA, Raska M, Wyatt RJ, Suzuki Y, Tomino Y, Gharavi AG, Mestecky J, Suzuki H.
    Adv Otorhinolaryngol; 2011 Dec; 72():60-3. PubMed ID: 21865691
    [Abstract] [Full Text] [Related]

  • 11. Loss of the Golgi Matrix Protein 130 Cause Aberrant IgA1 Glycosylation in IgA Nephropathy.
    Wang C, Ye M, Zhao Q, Xia M, Liu D, He L, Chen G, Peng Y, Liu H.
    Am J Nephrol; 2019 Dec; 49(4):307-316. PubMed ID: 30917363
    [Abstract] [Full Text] [Related]

  • 12. The role of tonsillectomy in IgA nephropathy.
    Feriozzi S, Polci R.
    J Nephrol; 2016 Feb; 29(1):13-9. PubMed ID: 26582216
    [Abstract] [Full Text] [Related]

  • 13. Relationship between tonsils and IgA nephropathy as well as indications of tonsillectomy.
    Xie Y, Chen X, Nishi S, Narita I, Gejyo F.
    Kidney Int; 2004 Apr; 65(4):1135-44. PubMed ID: 15086452
    [Abstract] [Full Text] [Related]

  • 14. Methodological approaches to the analysis of IgA1 O-glycosylation in IgA nephropathy.
    Allen AC.
    J Nephrol; 1999 Apr; 12(2):76-84. PubMed ID: 10378662
    [Abstract] [Full Text] [Related]

  • 15. Tonsillar IgA1 as a possible source of hypoglycosylated IgA1 in the serum of IgA nephropathy patients.
    Itoh A, Iwase H, Takatani T, Nakamura I, Hayashi M, Oba K, Hiki Y, Kobayashi Y, Okamoto M.
    Nephrol Dial Transplant; 2003 Jun; 18(6):1108-14. PubMed ID: 12748342
    [Abstract] [Full Text] [Related]

  • 16. Differential glycosylation of polymeric and monomeric IgA: a possible role in glomerular inflammation in IgA nephropathy.
    Oortwijn BD, Roos A, Royle L, van Gijlswijk-Janssen DJ, Faber-Krol MC, Eijgenraam JW, Dwek RA, Daha MR, Rudd PM, van Kooten C.
    J Am Soc Nephrol; 2006 Dec; 17(12):3529-39. PubMed ID: 17050773
    [Abstract] [Full Text] [Related]

  • 17. O-glycosylation of serum IgD in IgA nephropathy.
    Smith AC, de Wolff JF, Molyneux K, Feehally J, Barratt J.
    J Am Soc Nephrol; 2006 Apr; 17(4):1192-9. PubMed ID: 16510764
    [Abstract] [Full Text] [Related]

  • 18. Quantitative change of IgA hinge O-glycan composition is a novel marker of therapeutic responses of IgA nephropathy.
    Iwatani H, Inoue T, Wada Y, Nagasawa Y, Yamamoto R, Iijima H, Takehara T, Imai E, Rakugi H, Isaka Y.
    Biochem Biophys Res Commun; 2012 Nov 23; 428(3):339-42. PubMed ID: 23098908
    [Abstract] [Full Text] [Related]

  • 19. Structural features of IgA molecules which contribute to IgA nephropathy.
    Feehally J, Allen AC.
    J Nephrol; 1999 Nov 23; 12(2):59-65. PubMed ID: 10378660
    [Abstract] [Full Text] [Related]

  • 20. Differential expression of glycogenes in tonsillar B lymphocytes in association with proteinuria and renal dysfunction in IgA nephropathy.
    Inoue T, Sugiyama H, Hiki Y, Takiue K, Morinaga H, Kitagawa M, Maeshima Y, Fukushima K, Nishizaki K, Akagi H, Narimatsu Y, Narimatsu H, Makino H.
    Clin Immunol; 2010 Sep 23; 136(3):447-55. PubMed ID: 20538527
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.